The N-end rule: Functions, mysteries, uses by Varshavsky, Alexander
Proc. Natl. Acad. Sci. USA
Vol. 93, pp. 12142-12149, October 1996
Biochemistry
This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences
elected on April 25, 1995.
The N-end rule: Functions, mysteries, uses
(ubiquitin/proteolysis/N-degron/peptide import/apoptosis)
ALEXANDER VARSHAVSKY*
Division of Biology, California Institute of Technology, Pasadena, CA 91125
Contributed by Alexander Varshavsky, August 6, 1996
ABSTRACT The N-end rule relates the in vivo half-life of
a protein to the identity of its N-terminal residue. Similar but
distinct versions of the N-end rule operate in all organisms
examined, from mammals to fungi and bacteria. In eu-
karyotes, the N-end rule pathway is a part of the ubiquitin
system. I discuss the mechanisms and functions of this
pathway, and consider its applications.
The half-lives of proteins in a living cell range from a few seconds
to many days. Among the functions of intracellular proteolysis are
the elimination of abnormal proteins, the maintenance of amino
acid pools in cells affected by stresses such as starvation, and the
generation of protein fragments that act as hormones, antigens,
or other effectors. Yet another function of proteolytic pathways
is selective destruction of proteins whose concentrations must
vary with time and alterations in the state of a cell. Metabolic
instability is a property of many regulatory proteins. A short in
vivo half-lifet of a regulator provides a way to generate its spatial
gradients and allows for rapid adjustments of its concentration (or
subunit composition) through changes in the rate of its synthesis.
Conditionally unstable proteins, long-lived or short-lived depend-
ing on the state of a cell, are often deployed as components of
control circuits. One example is cyclins-a family of proteins
whose destruction at specific stages of the cell cycle regulates cell
division and growth (3). In addition, many proteins are long-lived
as components of larger complexes such as ribosomes and
oligomeric proteins but are metabolically unstable as free sub-
units.
Features of proteins that confer metabolic instability are
called degradation signals, or degrons (4). The essential com-
ponent of one degradation signal, the first to be discovered, is
a destabilizing N-terminal residue of a protein (5-7). This
signal is called the N-degron. A set of N-degrons containing
different destabilizing residues yields a rule, termed the N-end
rule, which relates the in vivo half-life of a protein to the
identity of its N-terminal residue (Table 1 and Fig. 1). The
N-end rule pathway is present in all organisms examined,
including the bacterium E. coli (8, 10), the yeast (fungus) S.
cerevisiae (5, 9), and mammalian cells (1, 11) (Fig. 1).
The N-end rule was encountered in experiments that ex-
plored the metabolic fate of a fusion between ubiquitin (Ub)
and a reporter protein such as E. coli ,B-galactosidase (I3gal) in
S. cerevisiae (5). In yeast and other eukaryotes, Ub-X-f3gal is
cleaved, cotranslationally or nearly so, by Ub-specific process-
ing proteases at the Ub-,3gal junction. This cleavage takes
place regardless of the identity of the residue X at the
C-terminal side of the cleavage site, proline being the single
exception. By allowing a bypass of the normal N-terminal
processing of a newly formed protein, this finding (Fig. 2A)
yielded an in vivo method for generating different residues at
the N termini of otherwise identical proteins-a technical
advance that led to the N-end rule (5, 6).
In eukaryotes, the N-degron comprises at least two determi-
nants: a destabilizing N-terminal residue and an internal lysine (or
lysines) of a substrate (Fig. 2B) (9, 12, 14, 15). The Lys residue is
the site of formation of a multi-Ub chain (16, 17). Ub is a
76-residue protein whose covalent conjugation to other proteins
is involved in a multitude of processes-cell growth and differ-
entiation, signal transduction, DNA repair, transmembrane traf-
fic, and responses to stress, including the immune response. In
many of these settinigs, Ub acts through routes that involve
processive degradation of Ub-protein conjugates (18-21).
The binding of an N-end rule substrate by a targeting
complex is followed by formation of a substrate-linked
multi-Ub chain (22, 23). The ubiquitylated substrate is pro-
cessively degraded by the 26S proteasome-an ATP-
dependent, multisubunit protease (18, 20, 24, 25). The N-end
rule pathway is present in both the cytosol (1, 5, 11) and the
nucleus (J. A. Johnston and A.V., unpublished data). In this
paper, I summarize the current understanding of the N-end
rule. For a more detailed review, see ref. 26.
Definitions of Terms
The N-End Rule. A relation between the metabolic stability
of a protein and the identity of its N-terminal residue.
The N-Degron. For a degradation signal to be termed an
N-degron, it is necessary and sufficient that it contain a substrate's
initial or acquired N-terminal residue whose recognition by the
targeting machinery is essential for the activity of this degron.
The Pre-N-Degron. Features of a protein that are necessary
and sufficient, in the context of a given intracellular compart-
ment, for the formation of N-degron.
The N-End Rule Pathway.A set of molecular components that
is necessary and sufficient, in the context of a given intracellular
compartment, for the recognition and degradation of proteins
bearing N-degrons. This "hardware-centric" definition of the
pathway bypasses semantic problems that arise if, for example,
one and the same targeting complex recognizes not only N-
degrons but also a degradation signal whose essential determi-
nants do not include the N-terminal residue of a substrate. This
definition also encompasses a setting where N-degrons that bear
different destabilizing N-terminal residues are recognized by
distinct targeting complexes. As discussed below, neither of these
possibilities is entirely hypothetical.
Primary Destabilizing Residues. Destabilizing activity of these
N-terminal residues, denoted N-dP, requires their physical bind-
ing by a protein called N-recognin or E3. In eukaryotes, the type
Abbreviations: Ub, ubiquitin; ,3gal, 13-galactosidase; DHFR, dihydro-
folate reductase; N-dt, a tertiary destabilizing N-terminal residue;
N-ds, a secondary destabilizing N-terminal residue; N-dPm and N-dP2,
type 1 and type 2 primary destabilizing N-terminal residues, respec-
tively; Nt-amidase, N-terminal amidohydrolase; NtN-amidase,
amidohydrolase -specific for N-terminal Asn; R-transferase, Arg-
tRNA-protein transferase; L/F-transferase, Leu/Phe-tRNA-protein
transferase; ICE, interleukin-1l/3-converting enzyme; ER, endoplasmic
reticulum; comtoxin, codominance-mediated toxin; NLS, nuclear lo-
calization signal.
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tThe in vivo degradation of many short-lived proteins, including the
engineered N-end rule substrates, deviates from first-order kinetics
(1, 2). Therefore the term "half-life," if applied to an entire decay
curve, is a useful but often crude approximation. A more rigorous
terminology for describing nonexponential decay was proposed by
Levy et al. (1).
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Table 1. The N-end rule in E. coli and S. cerevisiae
Residue X
in X-,Bgal
Arg
Lys
Phe
Leu
Trp
Tyr
His
Ile
Asp
Glu
Asn
Gln
Cys
Ala
Ser
Thr
Gly
Val
Pro
Met
In vivo half-life of X-,Bgal, min
In E. coli In S. cerevisiae
2
2
2
2
2
2
>600
>600
>600
>600
>600
>600
>600
>600
>600
>600
>600
>600
>600
2
3
3
3
3
10
3
30
3
30
3
10
>1200
>1200
>1200
>1200
>1200
>1200
9
>1200
Approximate in vivo half-lives of X-,B-galactosidase (,3gal) proteins
in E. coli at 36°C (8) and inS. cerevisiae at 30°C (5, 9). A question mark
at Pro indicates its uncertain status in the N-end rule (see text).
1 binding site of N-recognin binds N-terminal Arg, Lys, or His-a
set of basic N-dP residues, whereas the type 2 site binds N-
terminal Phe, Leu, Trp, Tyr, or Ile-a set of bulky hydrophobic
N-dP residues (Figs. 3 and 5). Accordingly, the N-dP residues are
subdivided into type 1 (N-dP1) and type 2 (N-dP2) residues. The
N-dP residues of E. coli-Phe, Leu, Trp, and Tyr-are exclusively
type 2 (N-dP2) residues (Figs. 4 and 5C).
Secondary Destabilizing Residues. These N-terminal residues,
denoted N-ds, are Arg and Lys in E. coli; Asp and Glu in S.
cerevisiae; and Asp, Glu, and Cys in mammalian cells (Figs. 3-5).
In eukaryotes, destabilizing activity of N-ds residues requires their
accessibility to Arg-tRNA-protein transferase (R-transferase). In
bacteria such as E. coli, destabilizing activity of the N-ds residues
Arg and Lys requires their accessibility to Leu/Phe-tRNA-
protein transferase (L/F-transferase).
Tertiary Destabilizing Residues. N-terminal Asn and Gln
residues, denoted N-dt. Destabilizing activity of N-dt residues
requires their accessibility to N-terminal amidohydrolase (Nt-
amidase) (Fig. 5 A and B).
Stabilizing Residues. A stabilizing N-terminal residue is a
"default" residue, in that it is stabilizing because targeting com-
ponents of an N-end rule pathway do not bind to it (or modify it)
efficiently enough even in the presence of other determinants of
an N-degron. Gly, Val, and Met are stabilizing residues that are
common to all of the known N-end rules (Fig. 1).
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FIG. 1. Comparison of eukaryotic and bacterial N-end rules. Open
circles denote stabilizing residues. Purple, red, and yellow circles
denote, respectively, type 1, type 2, and type 3 primary destabilizing
residues (N-dP1, N-dP2, and N-dP3). Blue triangles denote secondary
destabilizing residues (N-ds). Green crosses denote tertiary destabi-
lizing residues (N-dt) (1, 5-11). A question mark at Pro indicates its
uncertain status (see the main text). A question mark above Ser
indicates its uncertain status in the reticulocyte N-end rule (1).
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FIG. 2. Mechanics of the N-end rule. (A) The Ub fusion technique.
Linear fusions of Ub to other proteins are cleaved at the last residue
of Ub, making it possible to produce different residues at the N-
termini of otherwise identical proteins (5, 11). Amino acid residues in
blue and red are stabilizing and destabilizing, respectively, in the S.
cerevisiae N-end rule (9). (B) The two-determinant organization of
eukaryotic N-degrons. d, a destabilizing N-terminal residue. A chain
of black ovals linked to the second-determinant lysine (K) denotes a
multi-Ub chain. (C) Cis recognition of the N-degron in one subunit of
a dimeric protein. The other subunit bears s, a stabilizing N-terminal
residue. (D) Trans recognition, in which the first (d) and second (K)
determinants of the N-degron reside in different subunits of a dimeric
protein (12). (E) The hairpin insertion model. A targeted N-end rule
substrate (in green) bearing a multi-Ub chain is shown bound to the
26S proteasome through the chain. The position of a targeting complex
containing N-recognin is unknown, and is left unspecified. Only the
20S core component of the 26S proteasome is shown. A red arrow
indicates the direction of net movement of the substrate's polypeptide
chain toward active sites in the interior of proteasome. By analogy with
the arrangement of signal sequences during transmembrane translo-
cation of proteins (13), it is proposed that a region of the substrate
upstream of its ubiquitylated lysine (K) does not move through the
proteasome during the substrate's degradation, and it may be released
intact following a cleavage in the vicinity of the lysine. Variants of this
model may also be relevant to the targeting of proteins that bear
internal or C-terminal degrons. (F) A model for the recognition of an
N-end rule substrate (9). The reversible binding of N-recognin to a
primary destabilizing N-terminal residue (d) of a substrate (step I)
must be followed by a capture of the second-determinant lysine (K) of
the substrate by a targeting complex containing a Ub-conjugating (E2)
enzyme (step II). It is unknown whether the lysine is captured by E2
(as shown here) or by N-recognin. Ubiquitylation of the substrate
commences once the targeting complex is bound to both determinants
of the N-degron (step III). This model does not specify, among other
things, the details of Ub conjugation (see the main text).
Components and Evolution of the N-End Rule Pathway
N-Recognin (E3). In S. cerevisiae, N-recognin is a 225-kDa
protein (encoded by UBR1) that selects potential N-end rule
substrates through the binding to their N-dP residues Phe, Leu,
Trp, Tyr,Ile, Arg, Lys, or His (26, 27). N-recognin has at least
two substrate-binding sites. The type 1 site is specific for the
basic N-terminal residues Arg, Lys, and His. The type 2 site is
specific for the bulky hydrophobic N-terminal residues Phe,
Leu, Trp, Tyr, and Ile (Fig. 3). At present, these sites are defined
through dipeptide-based competition experiments. Specifi-
cally, a dipeptide bearing a destabilizing N-terminal residue
was found to inhibit the degradation of a test N-end rule
substrate if that substrate's N-terminal residue was of the same
type (1 or 2) as the dipeptide's N-terminal residue (2, 11, 28).
A genetic dissection of the type 1 and type 2 sites in S.
cerevisiae N-recognin (Ubrlp) has shown that either of the sites
can be mutationally inactivated without significantly perturb-
ing the other site. Mutations that selectively inactivate the type
1 or the type 2 site are located within the e50-kDa N-terminal
region of the 225-kDa N-recognin (A. Webster, M. Ghislain,
and A.V., unpublished data). E3a, the mammalian counter-
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FIG. 3. The S. cerevisiae N-end rule pathway. Type 1 (N-dPi) and type
2 (N-dP2) primary destabilizing N-terminal residues are in purple and red,
respectively. Secondary (N-ds) and tertiary (N-dt) destabilizing N-
terminal residues are in blue and green, respectively. The yellow ovals
denote the rest of a protein substrate. The conversion of N-dt residues N
and Q into N-ds residues D and E is mediated by N-terminal amidohy-
drolase (Nt-amidase), encoded by NTAI. The conjugation of the N-dP1
residue R to N-ds residues D and E is mediated by Arg-tRNA-protein
transferase (R-transferase), encoded byATE1. A complex of N-recognin
and the Ub-conjugating (E2) enzyme Ubc2p catalyzes the conjugation of
activated Ub, produced by the Ub-activating (El) enzyme Ubalp, to a Lys
residue of the substrate, yielding a substrate-linked multi-Ub chain.
Ubalp-Ub and Ubc2p-Ub denote covalent (thioester-mediated) com-
plexes of these enzymes with Ub. A multiubiquitylated substrate is
degraded by the 26S proteasome. (Inset) A model of the targeting
complex. The 20-kDa Ubc2p E2 enzyme is depicted carrying activated Ub
linked to Cys-88 of Ubc2p through a thioester bond. Both the 52-kDa
Ntalp (Nt-amidase) and the 58-kDa Atelp (R-transferase) bind to the
225-kDa Ubrlp (N-recognin) in proximity to the type 1 substrate-binding
site of Ubrlp. In addition, Ntalp directly interacts with Atelp (see the
main text).
part of S. cerevisiae N-recognin, has been characterized bio-
chemically in extracts from rabbit reticulocytes (18). Another
mammalian N-recognin, termed E3,3, which apparently binds
to substrates bearing N-terminal Ala and Thr (and possibly
also Ser) (1, 11), has been described as well (18).
All eukaryotes examined have both Ub and the N-end rule
pathway. Some, but not all, prokaryotes contain Ub (29). The
bacterium E. coli lacks Ub but does have an N-end rule
pathway (Fig. 4) (8). Screens for mutations that inactivate this
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FIG. 4. The E. coli N-end rule pathway. Primary (N-dP) destabilizing
N-terminal residues L, F, W, and Y are in red. Secondary (N-ds)
destabilizing N-terminal residues R and K are in blue. The yellow ovals
denote the rest of a protein substrate. Conjugation of the N-dP residue L
to the N-ds residues R and K is mediated by Leu/Phe-tRNA-protein
transferase (L/F-transferase), encoded byaat (8). In vivo, L/F-transferase
appears to conjugate predominantly, if not exclusively, L (10). The
degradation of a substrate bearing an N-dP residue is carried out by the
ATP-dependent protease ClpAP, encoded by cipA and clpP. A question
mark denotes an ambiguity about the nature of N-recognin in E. coli.
FIG. 5. Comparison of enzymatic reactions that underlie the activity
of tertiary (N-dt) and secondary (N-ds) destabilizing residues in different
organisms. (A) Mouse (Mus musculus) L-cells and rabbit (Oryctolagus
cuniculus) reticulocytes (1, 11). (B) The yeast S. cerevisiae (9). (C) The
bacterium E. coli (8, 10). The E. coli N-end rule lacks N-dt residues. The
postulated mammalian NtQ-amidase (in A) remains to be identified.
pathway have identified three E. coli genes-clpA, clpP, and aat
(8, 10). Aat is a Leu/Phe-tRNA-protein transferase (L/F-
transferase). ClpA (81 kDa) and ClpP (21 kDa) form an
-750-kDa complex, ClpAP, which exhibits ATP-dependent
protease activity in vitro (30) and is a functional counterpart of
the eukaryotic 26S proteasome in the E. coli N-end rule
pathway (Fig. 4). ClpP exhibits a chymotrypsin-like proteolytic
activity in vitro (30). ClpA is the ATP-binding component of
ClpAP. In vitro studies have shown that ClpA can act as a
chaperone in the activation of RepA, the replication initiator
encoded by the plasmid P1 (32). In vivo ramifications of these
results, and in particular their relevance to the proteolytic
function of ClpAP in the E. coli N-end rule pathway (Fig. 4),
remain to be examined.
N-Terminal Amidases. The S. cerevisiae N-terminal
amidohydrolase (Nt-amidase), encoded by NTA1, is a 52-kDa
enzyme which deamidates Asn or Gln if they are located at the
N-terminus of a polypeptide (Figs. 3 and SB) (31, 33).
Stewart et al. (34) purified a porcine Nt-amidase that deami-
dates N-terminal Asn (N) but not Gln (Q), and isolated a cDNA
that encodes this enzyme. Grigoryev et al. (33) isolated and
characterized an s17-kb gene, termed Ntanl, that encodes a
mouse homolog of the porcine amidase, termed NtN-amidase.
The - 1.4-kb Ntanl mRNA is expressed in all of the tested mouse
tissues and cell lines. Construction of ntanlA mouse mutants is
under way (Y. T. Kwon and A.V., unpublished data).
Aminoacyl-tRNA-Protein Transferases. The S. cerevisiae
Arg-tRNA-protein transferase (R-transferase), encoded by
ATE1, is a 58-kDa enzyme which utilizes Arg-tRNA to argi-
nylate N-termini of polypeptides that bear Asp or Glu (Figs. 3
and 5B) (35). In contrast to S. cerevisiae, where only Asp and
Glu are N-ds residues, in mammals Cys is an N-ds residue as
well (11) (Table 1 and Fig. 1).
An extract prepared -2 hr after a crush injury to the rat sciatic
nerve from a segment of the nerve immediately upstream of the
crush site was found to conjugate an -10-fold higher amount of
[3H]arginine to the N termini of unidentified endogenous pro-
teins than an otherwise identical extract from the same region of
an unperturbed sciatic nerve (36). This finding suggested a
crush-induced increase in the level of N-end rule substrates
and/or a post-crush induction of the N-end rule pathway. No
post-crush increase in arginylation was observed with extracts
tertiary secondary primary
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from the optic nerve, which does not regenerate after a crush
injury, in contrast to the sciatic nerve (36).
R-transferase appears to be confined to eukaryotes, whereas
L/F-transferase is present in bacteria such as E. coli but is
apparently absent from eukaryotes. E. coli L/F-transferase is a
27-kDa enzyme encoded by the aat gene (10). In vivo, L/F-
transferase conjugates mainly, if not exclusively, Leu to N-
terminal Arg or Lys of a polypeptide substrate (10) (Fig. 4). E. coli
mutants lacking aat are unable to degrade N-end rule substrates
that bear N-terminal Arg or Lys. These data (8, 10) identified
L/F-transferase as a component of the E. coli N-end rule
pathway.
Ub-Conjugating Enzymes. The initial interaction between
an N-end rule substrate and N-recognin is of moderate affinity
(the inferred Kd 10 ,uM; ref. 26), but it becomes much
stronger if an internal lysine of the substrate is captured by a
targeting complex containing a Ub-conjugating (E2) enzyme
and N-recognin (E3). This capture initiates processive synthe-
sis of a lysine-linked multi-Ub chain. The E2 enzymes utilize
activated Ub, produced by the Ub-activating (El) enzyme, to
catalyze the formation of isopeptide bonds between the C-
terminal Gly-76 of Ub and e-amino groups of lysines in
acceptor proteins (Fig. 3) (18, 19, 37).
In at least some Ub-dependent systems (38), including appar-
ently the N-end rule pathway (V. Chau and A.V., unpublished
data), the pathway-specific Ub ligase-a complex of a recognin
(E3) and an E2 enzyme-catalyzes the transfer of the Ub moiety
(which is initially linked to a Cys residue of the El enzyme)
through a relay of Ub thioesters before conjugating Ub to a Lys
residue of a targeted substrate. In a substrate-linked multi-Ub
chain, the C-terminal Gly of one Ub moiety is joined to an
internal Lys of the adjacent Ub moiety, resulting in a chain of
Ub-Ub conjugates. In a multi-Ub chain linked to an N-end rule
substrate, only Lys-48 ofUb was found to be joined to another Ub
moiety within a chain (16). Recently, multi-Ub chains linked
through Lys-63, Lys-29, Lys-11, or Lys-6 of Ub have been
described as well (16, 17, 39-41). It is unknown whether these
chains play a role in the N-end rule pathway.
The N-End Rule As a Witness of Evolution. The hierarchic
organization of N-end rules, with their tertiary, secondary, and
primary destabilizing residues, is a feature more conserved in
evolution than either the Ub dependence of an N-end rule
pathway or the identity of enzymatic reactions that mediate the
activity of destabilizing residues. For example, in a bacterium
such as E. coli, which lacks the Ub system, the N-end rule has
both N-dS and N-dP residues (it lacks N-dt residues) (Figs. 1, 4,
and SC). The identities of N-ds residues in E. coli (Arg and Lys)
are different from those in eukaryotes (Figs. 1 and 5). Bacterial
and eukaryotic enzymes that implement the coupling between
N-ds and N-dP residues are also different: L/F-transferase in
E. coli and R-transferase in eukaryotes. Note, however, that
bacterial L/F-transferase and eukaryotic R-transferase cata-
lyze reactions of the same type (conjugation of an amino acid
to an N-terminal residue of a polypeptide) and utilize the same
source of activated amino acid (aminoacyl-tRNA) (Fig. 5).
The apparent confinement of R-transferase to eukaryotes
and of L/F-transferase to prokaryotes suggests that N-dS
residues were recruited late in the evolution of N-end rule,
after the divergence of prokaryotic and eukaryotic lineages.
The lack of sequence similarity between the yeast Nt-amidase
and the mammalian NtN-amidase, as well as the more narrow
specificity of the mammalian enzyme (Fig. 5 A and B) suggest
that the N-dt residues Asn and Gln became a part of the N-end
rule much later yet, possibly after the divergence of metazoan
and fungal lineages. If so, the N-end rule pathway may be an
especially informative witness of evolution: the ancient origins
of this proteolytic system, the simplicity and discreteness of
changes in the rule books of N-end rules among different
species, and the diversity of proteins that either produce or
target the N-degron should facilitate phylogenetic deduc-
tions-once the components of this pathway become charac-
terized across a broad range of organisms.
Code Versus Hardware. A given N-end rule is defined
operationally-for a set of proteins such as X-I3gals that differ
exclusively by their N-terminal residues. Existing evidence (9)
strongly suggests that the ranking aspect of an N-end rule-i.e.,
an ordering of relative destabilizing activities among 20 fun-
damental amino acids-is invariant from one protein reporter
to another in a given intracellular compartment. By contrast,
the actual in vivo half-lives may differ greatly among different
proteins bearing one and the same N-terminal residue (9). The
cause of these differences is the multicomponent nature of
underlying N-degrons (Fig. 2B).
A priori, one and the same N-end rule can be implemented
through vastly different assortments of targeting hardware. At
one extreme, each destabilizing N-terminal residue may be
bound by a distinct N-recognin. Conversely, a single N-
recognin may be responsible for the entire rule book of
destabilizing residues in a given N-end rule. The actual N-end
rule pathways lie between these extremes and happen to have
a hierarchic rather than "linear" structure (Figs. 3-5).
Targeting Complex of the N-End Rule Pathway
The known components of the S. cerevisiae N-end rule pathway
that mediate steps prior to the processive proteolysis of a
targeted substrate by the 26S proteasome are Nt-amidase
(Ntalp), R-transferase (Atelp), N-recognin (Ubrlp), a Ub-
conjugating (E2) enzyme (Ubc2p), and the Ub-activating (El)
enzyme (Ubalp) (Fig. 3) (22, 26, 27, 31, 35, 42). In addition to
a direct evidence for the physical association between N-
recognin and Ubc2p (22, 23), there is also circumstantial
evidence for the existence of a complex between N-recognin,
R-transferase, and Nt-amidase (31). Recently, a high-affinity
interaction between Ntalp and Atelp was demonstrated di-
rectly; other evidence suggests that both Ntalp and Atelp
interact with Ubrlp (M. Ghislain, A. Webster, and A.V.,
unpublished results). In a quaternary Ubc2p-Ubrlp-Ntalp-
Atelp complex suggested by these data, Atelp and Ntalp
interact with each other and with Ubrlp (Fig. 3).
Effects of overexpressing Nt-amidase and/or R-transferase in
S. cerevisiae not only suggested the existence of Ntalp-Atelp-
Ubrlp-Ubc2p complex but also led to the prediction that Ntalp
and Atelp are associated with Ubrlp in proximity to its type 1
substrate-binding site (31). In Fig. 3 diagram, a physical proximity
of the bound R-transferase to the type 1 site of N-recognin is
presumed to decrease the steric accessibility of this site to an
N-end rule substrate that bears an N-dP1 residue such as Arg and
approaches the type 1 binding site of N-recognin from the bulk
solvent. By contrast, a substrate that acquired Arg through
arginylation by the N-recognin-bound R-transferase would be
able to reach the (nearby) type 1 binding site of N-recognin
directly-without dissociating into the bulk solvent first-a fea-
ture known as substrate "channeling" in multistage enzymatic
reactions (43). The mechanics of channeling may involve diffu-
sion of an N-end rule substrate in proximity to surfaces of the
targeting complex, analogous to the mechanism of a bifunctional
enzyme dihydrofolate reductase (DHFR)-thymidylate syn-
thetase, where the channeling of dihydrofolate apparently results
from its movement across the surface of the protein (44).
The N-Degron and Pre-N-Degron
Nascent proteins contain N-terminal Met (fMet in pro-
karyotes), which is a stabilizing residue in the known N-end
rules (Fig. 1). Thus, the N-degron of an N-end rule substrate
must be produced from a pre-N-degron. In an engineered
N-end rule substrate, a pre-N-degron contains the N-terminal
Ub moiety whose removal by Ub-specific proteases yields the
protein's N-degron (Fig. 2A). This design of a pre-N-degron is
unlikely to be relevant to physiological N-end rule substrates,
because natural Ub fusions (including the precursors of Ub)
either contain a stabilizing residue at the Ub-protein junction
or bear a mutant Ub moiety that is retained in vivo (45-47).
The known Met-aminopeptidases remove N-terminal Met if
the second residue of a protein is stabilizing in the yeast N-end
rule (Fig. 1). The structural basis of this selectivity is the size
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of a residue's side chain (48-50). Specifically, the side chains
of the residues that are destabilizing in the yeast N-end rule are
larger than those of stabilizing residues. The exception is
Met-a bulky hydrophobic but stabilizing residue (Fig. 1).
Can there be just one or a few residues between N-terminal
Met and the site of cleavage that produces an N-degron? If so,
a short (-10 residues) N-terminal sequence might contain
both the recognition motif and the cleavage site(s) for a
relevant (unknown) processing protease. Screens for such
sequences, carried out in S. cerevisiae (51, 52), did identify
short (c 10 residues) N-terminal regions that conferred Ubrlp-
dependent metabolic instability on a reporter protein. Most of
the sequences identified by these screens were not similar to
each other, possibly because a very large number of 10-residue
N-terminal extensions can produce an N-degron in vivo,
analogous to a large number of N-terminal sequences that can
function as signals for protein translocation across the endo-
plasmic reticulum (ER) membrane (53).
Analysis of one N-terminal extension identified by Ghislain
et al. (52) has shown that it targets a reporter protein for
degradation while retaining its N-terminal Met (M. Gonzalez,
F. Levy, M. Ghislain, and A.V., unpublished data). This finding
suggests that N-recognin binds not only to N-degrons but also
to a degron that consists of an entirely internal sequence motif.
By contrast, two other examined extensions were found to be
cleaved after N-terminal Met, yielding destabilizing N-
terminal residues (51, 52). In sum, we are just beginning to
understand the processing reactions that yield a destabilizing
N-terminal residue in a non-polyprotein context.
Mechanics of N-Degron
Stochastic Capture Model. Studies with O3gal- and DHFR-
based N-end rule substrates (9, 12, 16) suggested a stochastic
view of the N-degron, in which specific Lys residues of an
N-end rule substrate can be assigned a probability of being
utilized as a ubiquitylation site. This probability depends on
time-averaged spatial position and mobility of a protein's Lys.
For some, and often for most, of the Lys residues in an N-end
rule substrate, the probability of serving as a ubiquitylation site
would be negligible because of the Lys's lack of mobility
and/or its distance from a destabilizing N-terminal residue. In
this "stochastic capture" model (Fig. 2F), the folded confor-
mation of a substrate would be expected to slow down or
preclude the search for a Lys residue, unless it is optimally
positioned in the folded substrate.
The bipartite design of N-degron (Fig. 2B) is likely to be also
characteristic of other Ub-dependent degradation signals-
present in a multitude of naturally short-lived proteins that
include cyclins (3), IKBa (54), and c-Jun (21). The first compo-
nent of these degrons is an internal region of a protein (instead
of its N-terminal residue) that is specific for each degradation
signal. The second component is an internal Lys residue (or
residues). A degron may also contain regulatory determinants
whose modification (e.g., phosphorylation/dephosphoryla-
tion) can modulate the activity of this degron (14, 21).
Cis-Trans Recognition and Subunit-Specific Degradation of
Oligomeric Proteins. The two determinants of N-degron can be
recognized either in cis or in trans (Fig. 2 C and D) (ref. 12; F.
Levy and A.V., unpublished data). Experiments that revealed the
trans-recognition have also brought to light a remarkable feature
of the N-end rule pathway: only those subunits of an oligomeric
protein that contain the ubiquitylation site (but not necessarily a
destabilizing N-terminal residue) are actually degraded (12).
What might be the mechanism of subunit-specific proteolysis? A
"simple" model is suggested by the binding of a substrate-linked
multi-Ub chain to a component of the proteasome (55). Specif-
ically, a subunit of an oligomeric substrate bound to the protea-
some through a subunit-linked multi-Ub chain may be the only
subunit that undergoes further mechanochemical processing by
ATP-dependent, chaperone-like components of the 26S protea-
some. These components mediate the unfolding and transloca-
tion steps that cause a movement of the subunit toward active sites
in the proteasome's interior, and in the process dissociate this
subunit from the rest of oligomeric substrate. In this mechanism,
the initial binding ofN-recognin to another subunit-the one that
bears a destabilizing N-terminal residue but not the Lys deter-
minant (Fig. 2C)-may be either too transient (lasting, in a
"productive" engagement, only long enough for a Lys to be
captured on a nearby subunit) or sterically unfavorable for the
delivery of this subunit to the interior of the proteasome.
Since other Ub-dependent degradation signals appear to be
organized similarly to the N-degron (a "primary" recognition
determinant and an internal lysine or lysines), subunit selectivity
is likely to be a general feature ofproteolysis by the Ub system (6).
Examples of physiologically relevant subunit-selective proteolysis
include the degradation of p53 in a complex with the papilloma-
viral protein E6 (38, 56) and the degradation of a cyclin in a
complex with a cyclin-dependent kinase (3).
The Hairpin Insertion Model and the Function ofthe Multi-Ub
Chain. Formation of a substrate-linked multi-Ub chain produces
an additional binding site (or sites) for components of the
proteasome (6, 55). The resulting increase in affinity-i.e., a
decrease in the rate of dissociation of the proteasome-substrate
complex- can be used to facilitate proteolysis. Suppose that a
rate-limiting step which leads, several steps later, to the first
proteolytic cleavage of the proteasome-bound substrate is an
unfolding of a relevant region of the substrate. If so, an increase
in stability of the proteasome-substrate complex, brought about
by the multi-Ub chain, should facilitate substrate degradation,
because the longer the allowed "waiting" time, the greater the
probability of a required unfolding event. Another (not mutually
exclusive) possibility is that a substrate-linked multi-Ub chain acts
as a proximity trap for partially unfolded states of a substrate. This
might be achieved through reversible interactions of the chain's
Ub moieties with regions of the substrate that undergo local
unfolding. A prediction common to both models is that the
degradation of a substrate whose conformation poses less of a
kinetic impediment to the proteasome should be less dependent
on Ub and ubiquitylation than the degradation of an otherwise
similar but more stably folded substrate.
How is a proteasome-bound, ubiquitylated protein directed
to the interior of the proteasome? This problem is analogous
to the one in studies of transmembrane channels for protein
translocation (13). Could the solutions be similar in these
systems, reflecting, perhaps, a common ancestry of transloca-
tion channels and proteasomes? A model in Fig. 2E proposes,
by analogy with translocation systems, a "hairpin" insertion
mechanism for the initiation of proteolysis by the 26S protea-
some. A biased random walk ("thermal ratchet") that is likely
to underlie the translocation of proteins across membranes
(13) may also be responsible for the movement of the sub-
strate's polypeptide chain through the proteasome, with cleav-
age products diffusing out from the proteasome's distal end
and thereby contributing to the net bias in the chain's bidi-
rectional saltations through the proteasome channel.
Two findings indicate that unfolding of a targeted N-end
rule substrate is a prerequisite for its degradation by the 26S
proteasome. Methotrexate-a folic acid analog and high-
affinity ligand of DHFR-can inhibit the degradation of an
N-end rule substrate such as Arg-DHFR by the N-end rule
pathway (57). This result suggests that a critical post-
ubiquitylation step faced by the proteasome includes a "suf-
ficient" conformational perturbation of the proteasome-
bound substrate. Further, it was shown that the N-end rule-
mediated degradation of a 17-kDa N-terminal fragment of the
70-kDa Sindbis virus RNA polymerase is not precluded by the
conversion of all of the fragment's 10 Lys residues into Arg
residues, which cannot be ubiquitylated (T. Rumenapf, J.
Strauss, and A.V., unpublished data). Thus, the ubiquitylation
requirement of previously studied N-end rule substrates may
be a consequence of their relatively stable conformations. The
binding of a largely unfolded substrate (such as a fragment of
Sindbis virus RNA polymerase) by the targeting complex of
the N-end rule pathway may be sufficient for delivery of the
substrate to the proteasome's active sites in the absence of a
multi-Ub chain. In the language of models in Fig. 2 E and F,
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the "waiting"' time for a bound and conformationally unstable
substrate may be short enough not to require the formation of
a dissociation-slowing device such as a multi-Ub chain.
Substrates and Functions of the N-End Rule Pathway
The N-End Rule and Osmoregulation in Yeast. A synthetic
lethal screen was used to isolate an S. cerevisiae mutant, termed
slnl (for synthetic lethal of N-end rule), whose viability
requires the presence of UBRI (58). SLN1 has been found to
encode a eukaryotic homolog of two-component regula-
tors-a large family of proteins previously encountered only in
bacteria (59). The properties of S. cerevisiae Slnlp are consis-
tent with it being a sensor component of the osmoregulatory
(HOG) pathway (60). Since an otherwise lethal hypomorphic
mutation in SLN1 can be suppressed by the presence of Ubrlp
(N-recognin) (58, 59), it is likely that one or more of the
proteins (e.g., kinases) whose activity is down-regulated by
Slnlp can also be down-regulated through their degradation by
the N-end rule pathway. The relevant physiological N-end rule
substrate(s) remains to be identified.
The N-End Rule and Peptide Import. Alagramam et al. (61)
have found that ubrlA yeast cells are unable to import di- and
tripeptides. Recent results (C. Byrd and A.V., unpublished
data) indicate that Ubrlp (N-recognin) controls the activity of
the peptide transporter Ptr2p, an integral plasma membrane
protein, by regulating the synthesis and/or metabolic stability
of PTR2 mRNA. In one model, a transcriptional repressor of
PTR2 is short-lived, being degraded by the N-end rule pathway.
Consistent with this mechanism, the control of PTR2 expres-
sion by Ubrlp was found to involve the Ub-conjugating (E2)
enzyme Ubc2p, a known component of the N-end rule pathway
(Fig. 3). Ubc4p E2 enzyme can partially compensate for the
absence of Ubc2p; a deletion of both UBC2 and UBC4 results
in cells that do not express Ptr2p and are unable to import
peptides, similarly to ubrlA cells.
A screen for mutants that allow a bypass of the requirement for
UBRI in peptide import identified a gene, CUP9, that encodes a
homeodomain-containing protein. Cup9p is short-lived; its deg-
radation requires UBRI (C. Byrd and A.V., unpublished data).
Cup9p is likely to be a transcriptional repressor of PTR2. Re-
markably, an earlier study (62) identified CUP9 as a gene whose
inactivation decreases the resistance of S. cerevisiae to the toxicity
of copper ions in the presence of a nonfermentable carbon
source, suggesting a role for Cup9p in detoxification of copper.
Although the connection between peptide import and resistance
to copper toxicity remains obscure, our findings, taken together
with the results of Knight et al. (62), suggest that the N-end rule
pathway may be involved in the control of both peptide import
and copper homeostasis.
On a Possible Function of the N-End Rule Pathway in
Apoptosis. Until recently, apoptosis ("programmed" cell
death) (63) was considered to be an attribute of multicellular
but not unicellular organisms. However, given the near-
identity of cells in a quasiclonal population of single-cell
organisms, selection pressures may favor the emergence of an
apoptotic response, for instance to a stress of starvation. By
killing a fraction of a cell population, this response may benefit
the rest of it. One example is the mazEF operon of E. coli that
encodes a toxin/antitoxin pair (64). The long-lived MazF
protein is toxic; the short-lived MazE binds to MazF and
counteracts its toxicity. If the expression of the mazEF operon
falls below a certain threshold, as can happen during starvation
in E. coli, the level of antitoxin MazE would decrease more
rapidly than the level of toxin MazF, resulting in a starvation-
induced programmed cell death (64). Before the identification
of mazEF in the E. coli chromosome, analogous pairs of genes
("addiction modules") have been found in a number of
plasmids, where they ensure the plasmids' retention in their
hosts. MazE is degraded by the protease ClpAP (64)-the
same protease that degrades N-end rule substrates in E. coli
(Fig. 4). It is unknown whether MazE contains a pre-N-degron
or another degron recognized by ClpAP.
An essential aspect of apoptosis in metazoans may also be
controlled by a pair (or pairs!) of proteins-"apoptosis mod-
ules"-that act similarly to bacterial addiction modules. Fur-
ther, we suggest that the short-lived component of an apoptosis
module may be an N-end rule substrate. One reason for
considering this idea is the facility (a single cut) and irrevers-
ibility of a process that can convert an initially long-lived
antitoxin component of an apoptosis module into a short-lived
protein degraded by the N-end rule pathway. Specifically, we
propose that the induction of apoptosis by interleukin-1f-
converting enzyme (ICE)-like proteases (65, 66) may proceed
through the cleavage of an (unknown) antitoxin component of
an apoptosis module by an ICE or ICE-like protease. This
cleavage, while not necessarily inactivating the antitoxin's
function as such, would expose a destabilizing residue at the N
terminus of a cleavage product, rendering it short-lived and
thereby releasing a previously inhibited, relatively long-lived
toxin. Implicit in this hypothesis is the assumption that a
cleavage of antitoxin by an ICE-like protease is, by itself,
insufficient (or not immediately sufficient) for the disruption
of antitoxin's function, and that processive degradation of a C-
terminal cleavage fragment of antitoxin by the N-end rule
pathway is a required post-cleavage step.
The known targets of ICE-family proteases contain Asp at
the P1 position and a small residue, typically Ala or Ser, at the
P1' position-the future N-terminus of the C-terminal cleav-
age fragment. Ala [and possibly also Ser in some settings (26)]
is a weakly destabilizing N-dP residue in the mammalian N-end
rule (1, 11). However, ICE-family proteases can also cleave
peptide bonds whose P1' position is occupied by Asn-a
strongly destabilizing N-dt residue in the N-end rule (Fig. SA).
Examples of proteins cleaved by ICE-family proteases at the
Asp-Asn bond include actin (65) and protein kinase CA (66).
In addition, the activation of at least one ICE-family protease
also involves its proteolytic cleavage at the Asp-Asn bond (67),
suggesting that the enzymatic activation of this or analogous
proteases may simultaneously render them short-lived in
vivo-a possible source of negative control.
In sum, the hypothesis invokes an effector of apoptosis which
is activated when its inhibitor is cleaved by an ICE-like
protease, perhaps at the Asp-Asn bond, yielding a short-lived
protein degraded by the N-end rule pathway. It is also possible
that an N-end rule substrate regulates apoptosis upstream of
ICE-like proteases. One prediction of the former model is that
metabolic stabilization of the presumed Asn-bearing (cleaved)
inhibitor, for example, through a perturbation of the N-end
rule pathway, may inhibit the apoptosis. This prediction can be
tested in mouse cells that lack the Asn-specific N-terminal
amidase (NtN-amidase) (Fig. 5A) (33). Construction ofntanlA
mouse mutants is under way (Y. T. Kwon and A.V., unpub-
lished data).
Ge Subunit of G Protein. Overexpression of the N-end rule
pathwaywas found to inhibit the growth of haploid but not diploid
cells (68). This ploidy-dependent toxicity was traced to the
enhanced degradation of Gpalp, the Ga subunit of the G protein
that regulates cell differentiation in response to mating phero-
mone. The half-life of newly formed Ga at 30°C is '50 min in
wild-type cells, '10 min in cells overexpressing the N-end rule
pathway, and >10 hr in cells lacking the pathway. The degrada-
tion of Ga is preceded by its multiubiquitylation (68). Like other
Ga subunits of G proteins, the S. cerevisiae Gpalp bears a
conjugated N-terminal myristoyl moiety, which appears to be
retained during the targeting of Gpalp for degradation. A
deletion of the first 88 residues of Gpalp greatly accelerates its
degradation but retains the requirement for Ubrlp (K Madura,
unpublished data). These data suggest that Ubrlp recognizes a
feature of Ga that is distinct from the N-degron. Another,
N-degron-based model invokes a trans-targeting mechanism (Fig.
2C and D).A G,-type Ga is short-lived in mouse cells as well (69),
consistent with the possibility that Ga subunits of other organ-
isms are also degraded by the N-end rule pathway. The activation
of mouse Ga shortens its in vivo half-life (69), suggesting an
adaptation-related function of Ga degradation.
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Sindbis Virus RNA Polymerase and Other Viral Proteins.
The Sindbis virus RNA polymerase, also called nsP4 (non-
structuralprotein 4), is produced by an endoproteolytic cleav-
age of the viral precursor polyprotein nsP1234 (70). The nsP4
protein bears N-terminal Tyr (an N-dP2 residue; Figs. 1 and
SA), and is degraded by the N-end rule pathway in reticulocyte
extract (71). Tyr is an N-terminal residue of other alphaviral
RNA polymerases as well (70), suggesting that these homologs
of Sindbis virus RNA polymerase are also degraded by the
N-end rule pathway. Whereas the bulk of newly formed nsP4
is rapidly degraded, a fraction of nsP4 in infected cells is
long-lived, presumably within a replication complex that con-
tains viral and host proteins (70).
There are many potential N-end rule substrates derived
from viral polyproteins (72). One of them is the integrase of
the human immunodeficiency virus (HIV), produced by cleav-
ages within the gag-pol precursor polyprotein. The processed
integrase bears N-terminal Phe (72), a strongly destabilizing
N-dP2 residue in the N-end rule (Fig. SA). Thus, it is possible
that, similarly to the Sindbis virus RNA polymerase, at least a
fraction of HIV integrase is short-lived in vivo.
c-Mos, a Protooncoprotein. This 39-kDa Ser/Thr-kinase is
expressed predominantly in male and female germ cells.
Sagata and colleagues (14, 73) have identified c-Mos as a
physiological substrate of the N-end rule pathway that is
targeted for degradation through its N-terminal Pro residue.
Met-Pro-Ser-Pro, the encoded N-terminal sequence of Xeno-
pus c-Mos, is conserved among all vertebrates examined (73).
Since the N-terminal Met-Pro peptide bond is readily cleaved
by the major cytosolic Met-aminopeptidases (48-50), the
initially second-position Pro is expected to appear at the N
terminus of nascent c-Mos cotranslationally or nearly so.
The activity of the Pro-based N-degron in c-Mos is inhibited
through the phosphorylation of Ser-2 [Ser-3 in the c-Mos open
reading frame (ORF)] (14, 73). During the maturation of
Xenopus oocytes c-Mos is phosphorylated partially and revers-
ibly, and therefore remains short-lived. Later-at the time of
germinal vesicle breakdown and the arrest of mature oocytes
(eggs) at the second meiotic metaphase, c-Mos becomes
long-lived, owing to its nearly stoichiometric phosphorylation
at Ser-2 (74). Fertilization or mechanical activation of a
Xenopus egg releases the meiotic arrest through the induced
degradation of c-Mos-caused by a nearly complete dephos-
phorylation of phosphoserine-2 (14, 73). Consistent with this
model of the N-degron in c-Mos, the replacement of Ser-2 with
Asp or Glu (whose negative charge mimics that of the phos-
phate group) rendered c-Mos long-lived, whereas the replace-
ment of Ser-2 with Ala yielded a constitutively unstable c-Mos
(73). Lys-33 (Lys-34 in the c-Mos ORF) is a major ubiquity-
lation site of the c-Mos N-degron (73).
In contrast to N-terminal Pro in the context of c-Mos, the
N-terminal Pro followed by the sequence His-Gly-Ser-. . . [this is
the context of engineered N-end rule substrates such as X-f3gal
and X-DHFR (5, 9)] did not confer a short half-life on a reporter
protein in either yeast or mammalian cells (F. Levy, T. Rumenapf,
and A.V., unpublished data). One interpretation of these results
is that the N-degron of c-Mos, whose conserved N-terminal
sequence is Pro-Ser-Pro-... , has a "degron-enabling" internal
determinant additional to, and perhaps specific for, the N-
terminal Pro. The c-Mos N-degron is the first example of
N-degron whose activity is regulated by phosphorylation (73).
Compartmentalized Proteins Retrotransported to the Cy-
tosol. In contrast to cytosolic and nuclear proteins, the proteins
that function in (or pass through) the ER, Golgi, and related
compartments often bear destabilizing N-terminal residues-the
consequence of cleavage specificity of signal peptidases, which
remove signal sequences from proteins translocated into the ER
(5, 6). Thus, one function of the N-end rule pathway might be the
degradation of previously compartmentalized proteins that
"leak" into the cytosol from compartments such as the ER (6).
Remarkably, it has been found that at least some compartmen-
talized proteins can be retrotransported to the cytosol through a
route that requires specific ER proteins. US11, the ER-resident
transmembrane protein encoded by cytomegalovirus, causes the
newly translocated major histocompatibility complex (MHC)
class I heavy chain to be selectively retrotransported back to the
cytosol, where the heavy chain is degraded by a proteasome-
dependent pathway (75). Similarly, CPY*, a defective vacuolar
carboxypeptidase of S. cerevisiae, is retrotransported to the cy-
tosol shortly after entering the ER, and is degraded in the cytosol
by a Ub/proteasome-dependent pathway that requires the Ubc7p
Ub-conjugating enzyme (76). Whether the N-end rule pathway
plays a role in the degradation of retrotransported proteins
remains to be determined.
Applications of N-Degron
The portability and modular organization of N-degrons make
possible a variety of applications whose common feature is the
conferring of a constitutive or conditional metabolic instability
on a protein of interest.
The N-Degron and Conditional Mutants. A frequent problem
with conditional phenotypes is their leakiness-i.e., unacceptably
high residual activity of either a temperature-sensitive (ts) protein
at nonpermissive temperature or a gene of interest in the "off'
state of its promoter. Another problem is the "phenotypic lag,"
which often occurs between the imposition of nonpermissive
conditions and the emergence of a relevant null phenotype.
In one application of the N-end rule to the problem of
phenotypic lag, a constitutive N-degron (produced as de-
scribed in Fig. 2A) was fused to a protein expressed from an
inducible promoter (77, 78). This method is constrained by the
necessity of using a heterologous promoter and by a consti-
tutively short half-life of a target protein, whose levels may
therefore be suboptimal under permissive conditions. An
alternative design is a portable, heat-inducible N-degron that
is inactive at a low (permissive) temperature but becomes
active at a high (nonpermissive) temperature (15). Linking this
degron to proteins of interest yields a new class of ts mutants,
called td (temperature-activated degron). The td method (15)
does not require an often unsuccessful search for a ts mutation
in a gene of interest.
The N-Degron and Conditional Toxins. A major limitation of
the current pharmacological strategies stems from the absence of
drugs that are specific for two or more independent molecular
targets. For reasons discussed elsewhere (7, 79), it is desirable to
have a therapeutic agent that requires the presence of two or
more predetermined targets in a cell for it to be killed, and that
would spare a cell if it lacks even one of these targets. Combining
two "conventional" drugs against two different targets in a
multidrug regimen would not attain this goal, because the two
drugs together would perturb not only cells containing both
targets but also cells containing just one of the targets. More
generally, it is desirable to have drugs that exhibit a combinatorial
selectivity, killing (or otherwise modifying) a cell if, and only if,
it contains a predetermined set of molecular targets and at the
same time lacks another predetermined set of molecular targets.
Therapeutic agents of this, currently unrealistic, selectivity are
likely to be free of side effects-the bane of present-day therapies
against diseases such as cancer.
A strategy for designing reagents that are sensitive to the
presence or absence of more than one target at the same time
has recently been proposed (7, 79). The key feature of new
reagents, termed comtoxins (codominance-mediated toxins), is
their ability to utilize codominance, a property characteristic of
many signals in proteins, including degrons and nuclear local-
ization signals (NLSs). Codominance refers to the following
property of these signals: each degron (or NLS) in a protein
bearing two or more degrons (or NLSs) can target the protein
for degradation (or transport to the nucleus) independently of
other degrons (or NLSs) in the same protein. The crucial
property of a degron-based comtoxin is that its intrinsic
toxicity is the same in all cells, whereas its half-life (and,
consequently, its steady-state level and overall toxicity) in a cell
depends on the cell's protein composition, specifically on the
presence of "target" proteins that have been chosen to define
the profile of a cell to be eliminated. The target proteins would
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bind to their ligands in a comtoxin molecule, and either
physically obstruct the recognition of degrons or inactivate
them catalytically, for example by phosphorylation. These and
related ideas are described elsewhere (7, 79).
We are exploring the feasibility of comtoxins by using the
N-degron as a degradation signal and the cytotoxic A-chains
of ricin or diphtheria toxin as effector domains (T. Suzuki, I. V.
Davydov, and A.V., unpublished data). Our current aim is to
determine whether the concept of comtoxins can be imple-
mented in the "easy" setting of a cell culture-without ad-
dressing, yet, the delivery problem, the immunogenicity of
protein drugs, and related concerns.
Epilogue
Although many things have been learned about the N-end rule
since its discovery 10 years ago, several key questions remain
unanswered or glimpsed at best. For example, the detailed
mechanics of targeting is not understood. Biochemical dissection
of the N-end rule pathway reconstituted in vitro from defined
(cloned) components will be essential for attaining this goal.
Crystallographic-quality structural information about N-
recognin and the entire targeting complexwill be required as well.
The recently emerged possibility that N-recognin may target not
only N-degrons but also other degradation signals adds yet
another level of complexity, which will have to be addressed.
Genetic screens for proteins degraded by the N-end rule
pathway are our best hope for bringing to light physiological
N-end rule substrates. It is already clear that at least some of these
substrates are conditionally unstable-for example, partitioned
between a short-lived free substrate and a long-lived complex of
the substrate with other proteins. In addition, for some substrates,
the rate-limiting step in their degradation may be a processing
(cleavage) event that produces an N-degron from a pre-N-
degron. If so, a significant fraction of extant substrate molecules
may bear a stabilizing N-terminal residue. Given these obstacles
to identifying physiological N-end rule substrates, they are likely
to be more numerous than is apparent at the present time.
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